Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Hopening Inc. is a dynamic entity within the healthcare sector, known for its innovative approach to enhancing medical solutions and patient care services. As a forward-thinking company, Hopening Inc. specializes in the development and distribution of cutting-edge medical technologies that aim to optimize healthcare delivery. The company is involved in various segments of the healthcare industry, including medical devices, telehealth solutions, and digital health platforms. These products and services significantly impact hospitals, clinics, and individual healthcare providers, facilitating improved patient outcomes and operational efficiency. Hopening Inc.'s efforts contribute significantly to the ongoing transformation of healthcare, focusing on accessibility and modernized patient care processes. The company's initiatives are particularly relevant in an era where digital transformation is reshaping traditional healthcare models. Hopening Inc. plays a crucial role in bridging technological advancements with health services, demonstrating a commitment to future-proofing healthcare systems through sustainable and scalable solutions.
Operating margin is thin at 1.37%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue declined 3.5% YoY. The question is whether this is cyclical or a structural shift.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
€16M
▼ -3.5% YoY
Net Income (TTM)
€351K
▼ -25.7% YoY
Op. Margin
1.37%
▲ +0.7pp YoY
ROIC
5.68%
▲ +2.9pp YoY
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow
N/A
Net Debt
-€245K
Net Cash Position
Cash & Equiv.
€2M
3Y CAGR: -0.7%
Continue Research